Related Experiment Video
Updated: Nov 15, 2025

Taste Exam: A Brief and Validated Test
Published on: August 17, 2018
Bitter Taste Receptor as a Therapeutic Target in Orthopaedic Disorders
Weyland Cheng1,2, Manye Yao1, Fangna Liu1
1Department of Orthopaedic Surgery, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, Henan, People's Republic of China.
Abstract:
Non-gustatory, extraoral bitter taste receptors (T2Rs) are G-protein coupled receptors that are expressed throughout the body and have various functional responses when stimulated by bitter agonists. Presently, T2Rs have been found to be expressed in osteoclasts and osteocytes where osteoclasts were capable of detecting bacterial quorum-sensing molecules through the T2R38 isoform. In the innate immune system, stimulating T2Rs induces anti-inflammatory and anti-pathogenic effects through the phospholipase C/inositol triphosphate pathway, which leads to intracellular calcium release from the endoplasmic reticulum. The immune cells with functional responses to T2R activation also play a role in bone inflammation and orthopaedic disorders. Furthermore, increasing intracellular calcium levels in bone cells through T2R activation can potentially influence bone formation and resorption. With recent studies finding T2R expression in bone cells, we examine the potential of targeting this receptor to treat bone inflammation and to promote bone anabolism.
Insights
Bitter taste receptors (T2Rs) are found in bone cells, influencing inflammation and bone remodeling. Targeting T2Rs may offer new treatments for bone disorders and promote bone growth.
Area of Science:
- Biochemistry
- Cell Biology
- Immunology
Background:
- Non-gustatory, extraoral bitter taste receptors (T2Rs) are G-protein coupled receptors found throughout the body.
- T2Rs are expressed in bone cells, including osteoclasts and osteocytes.
- Osteoclasts utilize the T2R38 isoform to detect bacterial quorum-sensing molecules.
Purpose of the Study:
- To investigate the role of T2Rs in bone cells.
- To explore the potential of T2R activation in treating bone inflammation and orthopaedic disorders.
- To examine T2R targeting for promoting bone anabolism.
Main Methods:
- Review of existing literature on T2R expression and function in bone cells.
- Analysis of the signaling pathways involved in T2R activation (e.g., phospholipase C/inositol triphosphate pathway).
- Examination of the effects of intracellular calcium release on bone cell activity.
Main Results:
- T2R activation in immune cells induces anti-inflammatory and anti-pathogenic effects.
- T2R activation in bone cells leads to intracellular calcium release, potentially influencing bone formation and resorption.
- Functional T2Rs are present in osteoclasts and osteocytes, suggesting a role in bone homeostasis.
Conclusions:
- T2R expression in bone cells presents a novel therapeutic target.
- Targeting T2Rs could offer new strategies for managing bone inflammation and orthopaedic conditions.
- Further research into T2R activation may unlock potential for anabolic bone therapies.
More Related Videos
Related Concept Videos
The Physiology of Taste
Taste Buds and Receptors
Gustation
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
The Tongue and Taste Buds
G-Protein Gated Ion Channels
Sensory...

